4.5 Article

Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach

期刊

CHEMMEDCHEM
卷 15, 期 8, 页码 680-684

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202000024

关键词

hydrazine-tetrazoles; MCR chemistry; docking protocol; aspartic protease; crystal structures

资金

  1. ITN Accelerated Early stage drug dIScovery (AEGIS) [675555]
  2. US National Institutes of Health (NIH) [2R01GM097082-05]
  3. European Lead Factory (IMI) [115489]
  4. Qatar National Research Foundation [NPRP6-065-3-012]
  5. COFUNDs ALERT [665250]
  6. Prominent [754425]
  7. KWF Kankerbestrijding grant [10504]
  8. European Research Council (ERC) [757913]
  9. Helmholtz Association's Initiative and Networking Fund, COFUNDs ALERT [665250]

向作者/读者索取更多资源

Pharmacophore searches that include anchors, fragments contributing above average to receptor binding, combined with one-step syntheses are a powerful approach for the fast discovery of novel bioactive molecules. Here, we are presenting a pipeline for the rapid and efficient discovery of aspartyl protease inhibitors. First, we hypothesized that hydrazine could be a multi-valent warhead to interact with the active site Asp carboxylic acids. We incorporated the hydrazine anchor in a multicomponent reaction and created a large virtual library of hydrazine derivatives synthetically accessible in one-step. Next, we performed anchor-based pharmacophore screening of the libraries and resynthesized top-ranked compounds. The inhibitory potency of the molecules was finally assessed by an enzyme activity assay and the binding mode confirmed by several soaked crystal structures supporting the validity of the hypothesis and approach. The herein reported pipeline of tools will be of general value for the rapid generation of receptor binders beyond Asp proteases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据